Perspectives

How biotech startups can protect their IP in university licensing and industry collaborations

How biotech startups can protect their IP in university licensing and industry collaborations

How biotech startups can protect their IP in licensing and industry collaborations Your science is solid, your patent is filed and the university is supportive.…
The key financial decisions and priorities for biotech startups

The key financial decisions and priorities for biotech startups

The key financial decisions and priorities for biotech startups At our latest webinar, Hoffmann & Partner walked founders through what financial infrastructure you actually need…
Deals, Mergers & Acquisitions: How to sell your company

Deals, Mergers & Acquisitions: How to sell your company

Bringing a therapeutic innovation to market requires more than great science—it also demands long-term strategic thinking about funding, ownership, IP, future partnerships, and potential exit…
How Novo Nordisk partners with academia, biotech companies and beyond

How Novo Nordisk partners with academia, biotech companies and beyond

How Novo Nordisk partners with academia, biotech companies and beyond Novo Nordisk began with a one-dollar insulin license. Today, it’s a global giant fighting more…
Navigating US & EU Patent Law for Startups – avoiding the common pitfalls

Navigating US & EU Patent Law for Startups – avoiding the common pitfalls

Navigating US & EU Patent Law for Startups – avoiding the common pitfalls If you want to protect your intellectual property with a patent, you…
Filing intellectual property (IP) on novel targets and epitopes

Filing intellectual property (IP) on novel targets and epitopes

Filing intellectual property (IP) on novel targets and epitopes Building a strong IP portfolio is complex, especially when securing patents for novel targets and epitopes.…
What’s the ideal deal structure to secure funding for biotech startups?

What’s the ideal deal structure to secure funding for biotech startups?

What’s the ideal deal structure to secure funding for biotech startups? As the biotech funding environment evolves, particularly in early seed and Series A rounds,…
Key strategies for biotech companies transitioning from early- to late-stage

Key strategies for biotech companies transitioning from early- to late-stage

Transitioning from early- to late-stage development is a pivotal phase for any biotech startup. This journey, often laden with both opportunities and challenges, requires a…
9 tips for scientists who want to become entrepreneurs

9 tips for scientists who want to become entrepreneurs

9 tips for scientists who want to become entrepreneurs In our latest event, hosted in Strasbourg and co-organized with KPMG, we explored what it takes…

Do you have a question? Get in touch

  info@baselaunch.ch

Contact us